Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Retracted: Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer
Saved in:
| Published in: | Computational and Mathematical Methods in Medicine |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2023
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|